CompoAtlas

Nicorette Gum

Originaltext auf Französisch.

In Kanada zugelassenes natürliches Gesundheitsprodukt

Die Analyse oraler Dosen ist ohne einen nachgewiesenen ausschließlich oralen Verabreichungsweg nicht anwendbar.

Zusammensetzung

Arzneilicher Inhaltsstoff und QuelleJe Dosiseinheit laut Quelle
Nicotine

Quelle : Tobacco leaves

2 mg

Nicht arzneiliche Inhaltsstoffe

Acesulfame Potassium, Hypromellose, Oxyde de magnésium, Saveur de cannelle, Spearmint flavour, Oxyde de fer noir, Amidon de maïs, Dioxyde de titane, Carbonate de sodium anhydre, Cire de Carnauba, Poly(sorbate) 80, acacia, Menthol synthétique, Huile de menthe poivrée, Saveur de menthe, Sucralose, Saveur de fruits, Bicarbonate de sodium, xylitol, Base de gomme

In Kanada empfohlene Dosen

BevölkerungsgruppeAlterMenge pro EinnahmeHäufigkeit
Adultesminimum : 18 ansminimum : 10 Gomme ; maximum : 20 GommeNon précisée

In Kanada zugelassene Verwendungen

Fast nicotine craving relief to help you quit. NICORETTE(R) Gum is a medicine that can help you stop smoking by reducing withdrawal symptoms and nicotine cravings. NICORETTE(R) Gum is a form of Nicotine Replacement Therapy (NRT) that can help double your chances of quitting successfully. NICORETTE(R) Gum provides a lower level of nicotine to your blood than cigarettes and allows you to slowly decrease your body's need for nicotine. It works as a temporary aid to help you quit smoking by reducing nicotine withdrawal symptoms such as irritability, frustration, anxiety, difficulty in concentration and restlessness. Without these powerful urges for the cigarettes you "need", getting rid of the "habit" cigarettes becomes much easier. The good news is that NICORETTE(R) Gum contains no tar or carbon monoxide, and therefore doesn't present the same medical risks as cigarettes. It can be used to quit immediately (Stop to Quit) or to quit gradually (REDUCE TO QUIT(R)) by reducing the number of cigarettes you smoke each day. For people who have not been able to quit before, the NICORETTE(R) REDUCE TO QUIT(R) program may increase the chances of quitting by over 4 times. To increase your chances of quitting, use with a stop smoking support program as identified in the enclosed User Guide. NICORETTE(R) Gum can help double your chances of quitting successfully. Although quitting smoking is preferable, NICORETTE(R) Gum can also be used as part of a REDUCE TO QUIT(R) program in which it is used to reduce the number of cigarettes smoked prior to quitting in smokers who are not able or ready to quit abruptly. It can also be used in cases in which you temporarily refrain from smoking, for example, in smoke-free areas or in other situations when you wish to avoid smoking. Combination Nicotine Replacement Therapy - patch + as needed gum versus the nicotine patch or gum alone is: o Clinically proven to increase your chances of quitting. o A clinically proven approach to increase your chances of quitting. o If you have relapse or experience tough/intense cravings or failed with gum alone, you can use NICORETTE® gum with the Patch at the same time to increase your chances of quit success. o Now you can have the combined support of NICODERM® patch and NICORETTE® as needed gum products together, for a successful quit. o Tackle cravings: NICODERM® (patch) for slow release constant support and NICORETTE as needed gum for an extra quick fix/dose when you really need to fight back the cravings / when something triggers intense cravings. o Combination therapy is 38%/1.38x more effective than using one Nicotine Replacement Therapy product alone. o Use NICODERM® patch + NICORETTE® gum together to increase your chance of quitting.

Originaltext auf Englisch.

Eine in Kanada zugelassene Verwendung ist keine in der Europäischen Union zugelassene gesundheitsbezogene Angabe. Beachten Sie das Register gesundheitsbezogener Angaben.

Warnhinweise in Kanada

Known Adverse Reactions : NICORETTE(R) Gum can cause: headache, light-headedness, hiccups, upset stomach, and other stomach problems, especially if chewed too quickly or not chewed correctly, burping, increased salivation, jaw ache, unusual taste in your mouth, gingivitis, irritated or inflamed tongue, bleeding gums, tongue discoloration and sores. Other common side effects include mouth or throat soreness, but most people get used to this with ongoing use. Most of these side effects occur when you first start taking the product depending on how much you are using. Allergic reactions (including symptoms of anaphylaxis) occur rarely during use. Signs of an overdose include nausea/upset stomach, drooling, headache, abdominal pain, vomiting, diarrhea, cold sweat, dizziness, disturbed hearing and vision, mental confusion, marked weakness, fainting, rapid heartbeat or difficulty breathing. At high doses, these symptoms may be followed by low blood pressure, weak and irregular pulse, breathing difficulties, extreme exhaustion, circulatory collapse and general convulsions.

Originaltext auf Englisch.

Contra-Indications : Do not use if you: o are pregnant or breast feeding, unless you have consulted with a doctor or pharmacist before using this product o are under 18 years of age o have a jaw disorder, or are allergic to nicotine or to any of the non-medicinal ingredients in the product. WARNING: Do not use if you are an occasional or non-smoker.

Originaltext auf Englisch.

Cautions and Warnings : WARNING: Nicotine is highly addictive. (phaeochromocytoma) or are taking any prescription medication. Before you use NICORETTE® Inhaler talk to your doctor or pharmacist if you have diabetes, because you may need to monitor your blood sugar levels more closely than normal when you stop smoking and start using this product.

Originaltext auf Englisch.

Produktdaten

Inhaber
Kenvue Canada Inc.
NPN oder DIN-HM
02091933
Status
Aktive Lizenz
Lizenzdatum
13. Dezember 2007
Überarbeitungsdatum
12. März 2025
Form
Gomme
Verabreichungsweg
Buccale
Art des Antrags
DIN de transition

Quelle

Amtlicher Health-Canada-Eintrag, Zulassung 02091933

Licensed Natural Health Products Database (LNHPD), Health Canada: zugelassene Produkte, Inhaltsstoffe, Dosierungen, Verwendungen und Warnhinweise, abgerufen am 27. Oktober 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Originaltext auf Englisch.

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

Originaltext auf Französisch.

Die unter demselben Namen in Europa verkaufte Rezeptur kann abweichen. Diese Angaben ersetzen keinen ärztlichen oder pharmazeutischen Rat.

Liste in der amtlichen Überarbeitung vom (Register: Licensed Natural Health Products Database (LNHPD), Health Canada: zugelassene Produkte, Inhaltsstoffe, Dosierungen, Verwendungen und Warnhinweise).

Das Produkt hat sich geändert? Fotografieren Sie die Verpackung.

Ist eine Angabe zu diesem Produkt falsch oder veraltet, ob Sie Leser oder Marke sind? Schreiben Sie an contact@compoatlas.com: Jede Korrektur wird im Korrekturprotokoll veröffentlicht.

Eingabetaste zum Analysieren, Umschalt+Eingabetaste für eine neue Zeile